The researchers found that SARS-CoV-2 triggers an inflammatory antiviral response in the adipose tissue (body fat) and causes its dysfunction.
Initiated in 2002, the award is given to fellows within the Weill Department of Medicine who have performed outstanding research. This year's finalists were presented at Medicine Grand Rounds on June 23.
Four faculty in the WDOM have received the ASCI Council Young Physician-Scientist Award. This prestigious award recognizes physician-scientists who are early in their first faculty appointment and have made notable achievements in their research.
The researchers analyzed data from the REGARDS Study, which tracked cardiovascular-related outcomes in over 20,000 people for a decade, to identify adverse social determinants of health that can lead to a higher likelihood of a fatal heart attack.
Dr. Reisman will serve as Director of Structural Heart Disease at NYP/Weill Cornell Medicine and as Co-Director of Structural Heart Disease for NYP/Queens and NYP/Brooklyn Methodist Hospital.
Published in the Journal of the American College of Cardiology, Drs. Jonathan Weinsaft and Jiwon Kim have shown that an echocardiogram is a useful tool in evaluating COVID-19 patients who have damage to the heart’s right ventricle.
This prestigious research award is a 5-year grant in the amount of $1.1 million and will support development and testing of Dr. Goyal’s novel strategy for deprescribing medication in older adults with heart failure.
A development program for junior faculty, LAMP provides participants with critical tools to accomplish their primary career goals as academicians in the field of medicine.
In response to the COVID-19 pandemic, faculty from across the Weill Department of Medicine have been pursuing critical research.
Dr. Lo and colleagues hope that by using adipsin or DUSP26 therapies, patients with type 2 diabetes will be spared from developing beta cell failure and thus spared from insulin injections.